» Articles » PMID: 33940284

Bacterial Efflux Transporters' Polyspecificity - a Gift and a Curse?

Overview
Specialty Microbiology
Date 2021 May 3
PMID 33940284
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

All mechanisms of clinical antibiotic resistance benefit from activities of polyspecific efflux pumps acting to reduce intracellular accumulation of toxins and antibiotics. In Gram-negative bacteria, the major polyspecific efflux transporters belong to the Resistance-Nodulation-cell Division (RND) superfamily of proteins, which are capable of expelling thousands of structurally diverse compounds. Recent structural and functional advances generated novel insights into mechanisms underlying the biochemical versatility of RND transporters. This opinion article reviews these mechanisms and discusses implications of the polyspecificity of RND transporters for bacterial survival and for the development of efflux pump inhibitors effective in clinics.

Citing Articles

Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria.

Chiang A, Dekker J Commun Med (Lond). 2024; 4(1):170.

PMID: 39210044 PMC: 11362173. DOI: 10.1038/s43856-024-00591-y.


TolC and EmrA1 contribute to multidrug resistance and modulation of host cell death.

Kopping E, Benziger P, Thanassi D J Bacteriol. 2024; 206(9):e0024624.

PMID: 39194223 PMC: 11411944. DOI: 10.1128/jb.00246-24.


The complete catalog of antimicrobial resistance secondary active transporters in : evolution and drug resistance perspective.

Chanket W, Pipatthana M, Sangphukieo A, Harnvoravongchai P, Chankhamhaengdecha S, Janvilisri T Comput Struct Biotechnol J. 2024; 23:2358-2374.

PMID: 38873647 PMC: 11170357. DOI: 10.1016/j.csbj.2024.05.027.


Thicket and Mesh: How the Outer Membrane Can Resist Tension Imposed by the Cell Wall.

Ryoo D, Hwang H, Gumbart J J Phys Chem B. 2024; 128(22):5371-5377.

PMID: 38787347 PMC: 11163421. DOI: 10.1021/acs.jpcb.3c08510.


Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.

Duffey M, Jumde R, da Costa R, Ropponen H, Blasco B, Piddock L ACS Infect Dis. 2024; 10(5):1458-1482.

PMID: 38661541 PMC: 11091901. DOI: 10.1021/acsinfecdis.4c00091.


References
1.
Grimsey E, Fais C, Marshall R, Ricci V, Ciusa M, Stone J . Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump. mBio. 2020; 11(3). PMC: 7267879. DOI: 10.1128/mBio.00465-20. View

2.
Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T . Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000; 44(12):3322-7. PMC: 90200. DOI: 10.1128/AAC.44.12.3322-3327.2000. View

3.
Klenotic P, Moseng M, Morgan C, Yu E . Structural and Functional Diversity of Resistance-Nodulation-Cell Division Transporters. Chem Rev. 2020; 121(9):5378-5416. PMC: 8119314. DOI: 10.1021/acs.chemrev.0c00621. View

4.
Kinana A, Vargiu A, May T, Nikaido H . Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump. Proc Natl Acad Sci U S A. 2016; 113(5):1405-10. PMC: 4747751. DOI: 10.1073/pnas.1525143113. View

5.
Tam H, Malviya V, Foong W, Herrmann A, Malloci G, Ruggerone P . Binding and Transport of Carboxylated Drugs by the Multidrug Transporter AcrB. J Mol Biol. 2019; 432(4):861-877. PMC: 7071731. DOI: 10.1016/j.jmb.2019.12.025. View